Sort
51,593 grants matching “hepatitis”
Developing antiviral agents that inhibit HCV translation
$652,409Ptc Therapeutics, Inc. · R44 · FY2004 · AI
microRNAs in Human Cancer
$652,367Gregory J Hannon · Cold Spring Harbor Laboratory · P01 · FY2008 · CA
Pathway Specific Functional Biomarkers for the Early Detection of Liver Cancer
$652,359Lopa Mishra · George Washington University · U01 · FY2021 · CA
Defining the targets of broad intervention antimalarial agents
$652,347Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2015 · AI
Hepatotoxic effects of perfluoroalkyl substances: a new epidemiological approach for studying environmental fatty liver disease
$652,194Vaia Lida Chatzi · University Of Southern California · R01 · FY2022 · ES
Neurobehavioral Effects of HIV &Host Genetics in China
$652,125University Of California San Diego · R01 · FY2005 · MH
PRESERVATION OF BETA CELL FUNCTION IN PREDIABETES: IGT AND IFG
$652,096Ralph A Defronzo · University Of Texas Hlth Science Center · R01 · FY2017 · DK
Assessing performance of a Hepatitis C Emergency Department (HepC-END) Screening Tool
$651,976Haesuk Park · University Of Florida · R01 · FY2024 · DA
Investigation of management and disease manifestations of viral hepatitis
$651,965Theo Heller · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State
$651,929Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2021 · HL
Kidney Health Biomarker Panels for Drug Toxicity and Prognosis in HIV Infection
$651,898Michael G Shlipak · Northern California Institute/Res/Edu · R01 · FY2015 · AG
Developmental Funds
$651,859Scott M Lippman · University Of California, San Diego · P30 · FY2020 · CA
Molecular MR Imaging of Hepatic Fibrogenesis
$651,816Peter D Caravan · Massachusetts General Hospital · R01 · FY2020 · DK
Molecular MR Imaging of Hepatic Fibrogenesis
$651,816Peter D Caravan · Massachusetts General Hospital · R01 · FY2019 · DK
Risk Factors for AIDS among Drug Users: Getting Close to Zero
$651,735Don C Des Jarlais · Beth Israel Medical Ctr (New York) · R01 · FY2015 · DA
Bio-digital Rapid Alert to Identify Neuromorbidity
$651,658Robert S. Clark · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · NS
HIV-Infected IDU Living with HCV Coinfection
$651,527Columbia University Health Sciences · R01 · FY2004 · DA
1/2 Alcohol Associated Comorbidities and Microbiome Evaluation in HIV (ACME HIV)
$651,512Matthew S Freiberg · Vanderbilt University Medical Center · U01 · FY2020 · AA
Studies of Atomic Bomb Survivors
$651,468Amy Berrington · Division Of Cancer Epidemiology And Genetics · ZIA · FY2010 · CA
RBP2 Biology and Pathobiology
$651,464William S Blaner · Columbia University Health Sciences · R01 · FY2025 · DK
HCV and HIV Progression in Women on HAART
$651,390Andrea A. Kovacs · University Of Southern California · R01 · FY2009 · AI
Intrathoracic Pressure Regulator for Resuscitation
$651,337Keith G Lurie · Advanced Circulatory Systems, Inc. · R44 · FY2010 · HL
Mechanisms of Insulin Resistance in Man
$651,329Rita Basu · Mayo Clinic Rochester · R01 · FY2010 · DK
Inflammation, Macrophage Differentiation, and Cancer
$651,310Zheng-Gang Liu · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
HCV Infection--Risk Factors for Progression
$651,304Harvard University (Sch Of Public Hlth) · R01 · FY2001 · CA